Pharma stocks outlook

Pharma sector to remain a market favourite due to earnings visibility, say analysts

by
Pharma sector to remain a market favourite due to earnings visibility, say analysts

Mumbai: The healthcare index hit a record high on Friday led by a rally in sector majors Lupin, Dr Reddy’s Laboratories and Cipla on the back of positive news flow. The sector will remain a market favourite due to earnings visibility, which does not exist for most sectors currently because of the pandemic. Analysts said … Read more

Expect pharma stocks to give 15% compounding returns over medium to long-term: Aditya Khemani

by
Expect pharma stocks to give 15% compounding returns over medium to long-term: Aditya Khemani

We are not positive but neutral when it comes to the construction or infrastructure space, said Fund Manager, MOAMC. Let us take stock of the earnings so far. Post Axis Bank’s moratorium confusion, it seems like the Street has absorbed the earnings well. I cannot comment on individual stocks but if we look at the … Read more